FNY Investment Advisers’s Surmodics SRDX Stock Holding History

FNY Investment Advisers’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,000	Closed	-$179K	–	1440
2025 Q3	$179K	Buy	6,000 +2,000	+50%	+$66.8K	0.06%	290
2025 Q2	$118K	Hold	4,000	–	–	0.05%	283
2025 Q1	$122K	Sell	4,000 -3,500	-47%	-$118K	0.07%	195
2024 Q4	$297K	Hold	7,500	–	–	0.15%	134
2024 Q3	$290K	Buy	+7,500	New	+$303K	0.14%	134

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's SRDX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 6,000 shares — an estimated $179K sold.

FNY Investment Advisers first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $297K in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

FNY Investment Advisers reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
FNY Investment Advisers sold 6,000 Surmodics shares in Q4 2025, an estimated $179K.
FNY Investment Advisers first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
FNY Investment Advisers's Surmodics position peaked at $297K in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.